Neoadjuvant endocrine therapy in breast cancer premenopausal patients. Literature review and research results
Smolanka I.I.1, Ivankova O.N.1, Ignat M.V.2, Lygyrda O.F., Lyashenko A.O. 1
Summary. The use of neoadjuvant endocrine therapy in the breast cancer complex treatment in premenopausal patients remains controversial. We study the efficacy of neoadjuvant endocrine therapy in premenopausal women with locally advanced breast cancer . Overall clinical response was obtained in all patients. Partial response was received in 91,89% of cases, stabilization in 8,11%. All patients underwent radical surgery, breast conserving surgerywere performed in 89,19%.
Leave a comment